Results 131 to 140 of about 315,361 (205)

Insights into ectodomain shedding as a novel target in natural killer cell-based immunotherapy for cancer. [PDF]

Front Immunol
Pimenta R, Arai J, Ribeiro de Lima Brandao L, Schmidt P, da Silva Bortoleti BT, Ferrari de Andrade L.   +5 more
europepmc   +1 more source

Antibody-dependent cellular phagocytosis in cancer immunotherapy: research and perspectives. [PDF]

J Transl Med
Gu Q, Li S, Hou S, Liu J, Zhang X, Xi Y, Chen H, Liu S, Chu M, Yang M.   +9 more
europepmc   +1 more source

Pteryxin enhances human NK-cell cytotoxicity by upregulating NKp30, NKp46, and 2B4 via ERK/AKT signaling. [PDF]

Front Pharmacol
Park ES, Kim JT, Hwang YS, Han J, Park HM, Yoon HR, Cho HJ, Lee HG.   +7 more
europepmc   +1 more source

Targeting ST3GAL1 to downregulate ligands for the glycoimmune checkpoint Siglec-7 and reverse immune escape in hepatocellular carcinoma. [PDF]

Cancer Immunol Immunother
Fan TC, Hung TH, Yeh CT, Lin PT, Chang NC, Lo TC, Wu TJ, Yu J, Yu AL.   +8 more
europepmc   +1 more source

Ramantamig (JNJ-79635322), a novel T-cell-engaging trispecific antibody targeting BCMA, GPRC5D, and CD3, in multiple myeloma models.

Blood
Pillarisetti K, Yang D, Luistro L, Yao J, Smith M, Vulfson P, Testa JS, Ponticiello R, Brodeur S, Heidrich B, Packman K, Singh S, Attar R, Elsayed Y, Philippar U.   +14 more
europepmc   +1 more source

Multiple roles of humoral responses in the control of HIV infection. [PDF]

Curr Opin HIV AIDS
Pons-Grífols A, Trinité B, Blanco J.
europepmc   +1 more source

Integrin-specific binding macrocyclic RGD peptides functionalized with dinitrophenol as multivalent antibody-recruiting molecules to enhance cytotoxicity in cancer immunotherapy. [PDF]

RSC Med Chem
Cheng X, Hu C, Gao W, Chen Y, Wang W, Zhu G, Wu Z.   +6 more
europepmc   +1 more source

NDV-GT wth hyperacute rejection in cancer therapy. [PDF]

Virus Res
Li Z, Chen H, Wang Z, Liu X, Qu S.
europepmc   +1 more source

PD-1 blockade does not enhance alloimmunization after allogeneic dendritic cell vaccination in cancer patients. [PDF]

Front Immunol
Planel S, Vayssière G, Maggipinto G, Leplus E, Laulagnier K, Renard F, Myster F, Gerard M, Demedts I, Cuppens K, Pons-Tostivint E, Wauters E, Borm FJ, Sibille A, Colinet B, Pérol M, Theelen WSME, Biesma B, Van De Kerkhove C, Buchmeier E, Althoff FC, Derijcke S, Moro-Sibilot D, Cantero F, Chaperot L, Saas P, Skrzypski M, Vansteenkiste J, Plumas J.   +28 more
europepmc   +1 more source